Group One Trading
BBIO icon

Group One Trading’s BridgeBio Pharma BBIO Stock Holding History

Group One Trading’s Portfolio BBIO Stock Details BBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.91M Sell
52,700
-30,300
-37% -$2.2M 0.01% 1493
2025
Q4 		$6.35M Sell
83,000
-5,300
-6% -$348K 0.01% 1284
2025
Q3 		$4.59M Sell
88,300
-16,900
-16% -$824K 0.01% 1555
2025
Q2 		$4.54M Sell
105,200
-9,600
-8% -$349K 0.01% 1397
2025
Q1 		$3.97M Sell
114,800
-64,500
-36% -$2.17M 0.01% 1260
2024
Q4 		$4.92M Sell
179,300
-20,400
-10% -$527K 0.01% 1187
2024
Q3 		$5.08M Buy
199,700
+24,800
+14% +$651K 0.01% 990
2024
Q2 		$4.43M Buy
174,900
+77,300
+79% +$2.11M 0.02% 878
2024
Q1 		$3.02M Buy
97,600
+11,900
+14% +$405K 0.01% 1180
2023
Q4 		$3.46M Sell
85,700
-88,900
-51% -$2.67M 0.01% 1416
2023
Q3 		$4.6M Buy
174,600
+7,700
+5% +$219K 0.02% 985
2023
Q2 		$2.87M Sell
166,900
-157,100
-48% -$2.36M 0.01% 1395
2023
Q1 		$5.37M Buy
324,000
+318,500
+5,791% +$3.71M 0.02% 806
2022
Q4 		$41.9K Sell
5,500
-58,500
-91% -$560K ﹤0.01% 5131
2022
Q3 		$636K Buy
64,000
+41,400
+183% +$430K ﹤0.01% 2994
2022
Q2 		$205K Sell
22,600
-3,900
-15% -$32.6K ﹤0.01% 4283
2022
Q1 		$269K Sell
26,500
-178,000
-87% -$1.83M ﹤0.01% 4481
2021
Q4 		$3.41M Buy
204,500
+181,900
+805% +$7.7M ﹤0.01% 2059
2021
Q3 		$1.06M Sell
22,600
-4,900
-18% -$263K ﹤0.01% 3349
2021
Q2 		$1.68M Sell
27,500
-5,800
-17% -$331K ﹤0.01% 2837
2021
Q1 		$2.05M Buy
33,300
+28,300
+566% +$1.85M ﹤0.01% 2440
2020
Q4 		$356K Buy
+5,000
New +$241K ﹤0.01% 3575
2020
Q3 		– Sell
-500
Closed -$16K – 6072
2020
Q2 		$16K Buy
+500
New +$15.2K ﹤0.01% 4915

Other funds holding BBIO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Group One Trading's BBIO Position: Q4 2025 in Review

Group One Trading sold out of BridgeBio Pharma (BBIO) in Q4 2025, closing a stake of 33,537 shares — an estimated $2.2M sold.

Group One Trading first reported a position in BBIO in Q4 2021 and held it in 11 quarters. The position peaked at $6.4M in Q4 2024. 432 funds tracked by Wall St. Rank hold BBIO as of Q4 2025.

  • Group One Trading reported no remaining BridgeBio Pharma position as of Q4 2025 after selling out during the quarter.
  • Group One Trading sold 33,537 BridgeBio Pharma shares in Q4 2025, an estimated $2.2M.
  • Group One Trading first reported a position in BridgeBio Pharma in Q4 2021 and held it in 11 quarters.
  • Group One Trading's BridgeBio Pharma position peaked at $6.4M in Q4 2024.
  • 432 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q4 2025.

Based on Group One Trading's 13F filing for Q4 2025, filed 12 Feb 2026.